Synthetic Biology Market Revenue, Growth, Developments, Size, Share and Forecast 2030

Synthetic Biology Market was valued at USD 14.62 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 25.4% from 2024 to 2030, reaching nearly USD 71.30 billion by the end of the forecast period.

Overview

Synthetic biology is an interdisciplinary field that combines principles from biotechnology, genetic engineering, molecular biology, and systems biology to design and construct new biological parts, devices, and systems. It also involves the redesign of existing natural biological systems for useful purposes. The field leverages modern techniques such as high-throughput DNA technologies and bioinformatics to achieve precise control over biological systems, enabling applications across various industries including healthcare, agriculture, and environmental science.​

To Know More About This Report Request A Free Sample Copy: https://www.maximizemarketresearch.com/request-sample/616/

Market Scope

The synthetic biology market encompasses a wide range of tools, technologies, and applications. Key tools include synthetic DNA, synthetic genes, and chassis organisms. Technologies driving the market comprise genome engineering, DNA sequencing, bioinformatics, and biological components and integrated systems. Applications span across healthcare, agriculture, chemicals, and others, with healthcare being a significant contributor due to the development of novel therapeutics and diagnostics.​

Segmentation

By Tool:

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids​

By Technology:

• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modeling
• Microfluidics
• Nanotechnology​

By Application:

• Pharmaceuticals & Drug Discovery
• Artificial Tissue and Tissue Regeneration
• Industrial
• Food & Agriculture
• Environmental​

By Product:

• Core Products
• Enabling Products
• Enabled Products​

By Region:

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America​

Major Manufacturers:

• Thermo Fisher Scientific
• Merck KGaA
• Agilent Technologies, Inc.
• Novozymes A/S
• Genscript Corporation
• Amyris
• Intrexon
• Dupont
• Twist Bioscience
• Synthetic Genomics Inc.​

Regional Analysis:

United States

The U.S. leads the synthetic biology market in North America, driven by advancements in genome engineering, bioinformatics, and widespread applications across healthcare, agriculture, and chemical industries. The presence of leading biotechnology companies, academic institutions, and supportive government initiatives positions the United States as a key player in shaping the regional synthetic biology market.​

Germany

Germany represents a significant market within Europe, with a strong focus on research and development in biotechnology and synthetic biology. The country's robust healthcare infrastructure and emphasis on innovation contribute to the adoption of synthetic biology applications, particularly in pharmaceuticals and industrial biotechnology.​

COVID-19 Impact Analysis

The COVID-19 pandemic underscored the importance of rapid and flexible biotechnological solutions, highlighting the potential of synthetic biology in developing diagnostics, therapeutics, and vaccines. The crisis accelerated investments and research in synthetic biology, leading to increased adoption of bioinformatics tools and genome engineering techniques to combat emerging health threats.​

Key Questions Answered:

• What is the projected market size of the global synthetic biology market by 2030?
• Which tools and technologies are driving the growth of synthetic biology?
• How are different regions contributing to the expansion of the synthetic biology market?
• What impact did COVID-19 have on the synthetic biology industry?
• Who are the major players in the global synthetic biology market?​

About Maximize Market Research

Maximize Market Research is a global market research and consulting company specializing in various industries, including healthcare, pharmaceuticals, and biotechnology. The firm provides in-depth market analysis, strategic insights, and comprehensive reports to assist businesses in making informed decisions and achieving sustainable growth.​

Conclusion

The global synthetic biology market is poised for significant growth, driven by advancements in bioinformatics, genome engineering, and a wide array of applications across multiple industries. With a projected market size of USD 71.30 billion by 2030, stakeholders are expected to witness substantial opportunities in this rapidly evolving field. Continued investments in research and development, along with supportive regulatory frameworks, will be crucial in harnessing the full potential of synthetic biology.​